DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Methylation of CpG islands is associated with transcriptional silencing and the formation of nuclease-resistant chromatin structures enriched in hypoacetylated histones. Methyl-CpG-binding proteins, such as MeCP2, provide a link between methylated DNA and hypoacetylated histones by recruiting histone deacetylase, but the mechanisms establishing the methylation patterns themselves are unknown. Whether DNA methylation is always causal for the assembly of repressive chromatin or whether features of transcriptionally silent chromatin might target methyltransferase remains unresolved. Mammalian DNA methyltransferases show little sequence specificity in vitro, yet methylation can be targeted in vivo within chromosomes to repetitive elements, centromeres and imprinted loci. This targeting is frequently disrupted in tumour cells, resulting in the improper silencing of tumour-suppressor genes associated with CpG islands. Here we show that the predominant mammalian DNA methyltransferase, DNMT1, co-purifies with the retinoblastoma (Rb) tumour suppressor gene product, E2F1, and HDAC1 and that DNMT1 cooperates with Rb to repress transcription from promoters containing E2F-binding sites. These results establish a link between DNA methylation, histone deacetylase and sequence-specific DNA binding activity, as well as a growth-regulatory pathway that is disrupted in nearly all cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DNA methyltransferase DNMT1, which is both an E2F target112 and a RB–E2F protein binding partner118, has been shown to be upregulated in human cancers and in response to loss of RB.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [118]
Citations
Cites
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984 · cited 1×
“DNA methylation at CpG dinucleotides is essential for embryonic development and is catalysed by three DNA methyltransferases, DNMT1, DNMT3a and DNMT3b, which have differential capacities for maintenance and de novo methylatio”
BackgroundNan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,730
Self-citationCancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Self-citationXu, G.-L., Bestor, T. H., Bourc'his, D., Hsieh, C.-L., Tommerup, N., Bugge, M., Hulten, M., Qu, X., Russo, J. J., & Viegas-Péquignot, E. (1999) · Nature · doi:10.1038/46052 · Cited by 1,203
A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei
Leonhardt, H., Page, A. W., Weier, H.-U., & Bestor, T. H. (1992) · Cell · doi:10.1016/0092-8674(92)90561-p · Cited by 1,055
DNA methyltransferase Dnmt1 associates with histone deacetylase activity
Fuks, F., Burgers, W. A., Brehm, A., Hughes-Davies, L., & Kouzarides, T. (2000) · Nature Genetics · doi:10.1038/71750 · Cited by 994
Rb Interacts with Histone Deacetylase to Repress Transcription
Luo, R. X., Postigo, A. A., & Dean, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)80940-x · Cited by 960
Retinoblastoma protein represses transcription by recruiting a histone deacetylase
Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., & Harel-Bellan, A. (1998) · Nature · doi:10.1038/35410 · Cited by 909
Cited by
Items 101–111 of 111
PU.1 and pRB Interact and Cooperate To Repress GATA-1 and Block Erythroid Differentiation
Rekhtman, N., Choe, K. S., Matushansky, I., Murray, S., Stopka, T., & Skoultchi, A. I. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7460-7474.2003 · Cited by 102
“pRB has been shown to mediate transcriptional repression by recruiting to promoters several different types of chromatin remodeling activities, including enzymes that catalyze posttranslational modifications of histones, specifically histone deacetylases and histone methyltransferase, as well as complexes that alter t…”
BackgroundTranscriptional regulation of cellular senescence
Lanigan, F., Geraghty, J. G., & Bracken, A. P. (2011) · Oncogene · doi:10.1038/onc.2011.34 · Cited by 95
HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications
Harada, T., Ohguchi, H., Grondin, Y., Kikuchi, S., Sagawa, M., Tai, Y.-T., Mazitschek, R., Hideshima, T., & Anderson, K. C. (2017) · Leukemia · doi:10.1038/leu.2017.144 · Cited by 89
Dick, F. A. (2007) · Cell Division · doi:10.1186/1747-1028-2-26 · Cited by 79
“Some of these proteins have an enzymatic activity or other property that can modify chromatin structure, these include BRG1, Brm, DNMT1, HDAC1 and 2, HP1, RBP2, RIZ1, and Suv39h1 [19-23,79- 83].”
BackgroundSuzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., & Oikawa, T. (2003) · Oncogene · doi:10.1038/sj.onc.1207182 · Cited by 87
2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter
Yang, Z., Jiang, B., Wang, Y., Ni, H., Zhang, J., Xia, J., Shi, M., Hung, L.-M., Ruan, J., Mak, T. W., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.012 · Cited by 78
The Rb/chromatin connection and epigenetic control: opinion
Ferreira, R., Naguibneva, I., Pritchard, L. L., Ait-Si-Ali, S., & Harel-Bellan, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204337 · Cited by 76
Self-citationDNA‐damage‐responsive acetylation of pRb regulates binding to E2F‐1
Markham, D., Munro, S., Soloway, J., O'Connor, D. P., & La Thangue, N. B. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400591 · Cited by 62
Senescence and epigenetic dysregulation in cancer
Neumeister, P., Albanese, C., Balent, B., Greally, J., & Pestell, R. G. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00079-1 · Cited by 56
Retinoblastoma tumor suppressor and genome stability
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)85002-3 · Cited by 48
Koenig, M. J., Agana, B. A., Kaufman, J. M., Sharpnack, M. F., Wang, W. Z., Weigel, C., Navarro, F. C. P., Amann, J. M., Cacciato, N., Arasada, R. R., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3199 · Cited by 18
Metadata
- Authors
- Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wolffe, Alan P.
- Venue
- Nature Genetics
- Published
- 2000-07
- Volume
- 25
- Issue
- 3
- Pages
- 338-342
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1521333964
- Cited by
- 942
- References
- 29
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 9 · 2023: 22 · 2022: 22 · 2021: 13 · 2020: 17 · 2019: 21 · 2018: 31 · 2017: 22 · 2016: 35 · 2015: 25 · 2014: 35 · 2013: 24 · 2012: 48
- FWCI
- 23.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- DNMT1, DNA methyltransferases, retinoblastoma protein, E2F1, HDAC1, histone deacetylase, transcriptional repression, CpG islands, DNA methylation, histone hypoacetylation, repressive chromatin, tumor suppressor, protein complex formation
- MeSH terms
- DNA (Cytosine-5-)-Methyltransferase 1, Animals, Carrier Proteins, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, HeLa Cells, Histone Deacetylases, Humans, Promoter Regions, Genetic, Recombinant Fusion Proteins, Transcription Factors, Transcription, Genetic, Retinoblastoma Protein, 3T3 Cells, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, Response Elements, Transcription Factor DP1, E2F Transcription Factors, E2F1 Transcription Factor, Mice, Histone Deacetylase 1, Retinoblastoma-Binding Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.